Irritable bowel syndrome: Role of food in pathogenesis and management

Journal of Digestive Diseases

Volumn 10, Issue 4, 2009, Pages 237-246

  Morcos, Ashraf ^a   Dinan, Ted ^b   Quigley, Eamonn M M ^c  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c University College Cork and INFANT Centre   (Ireland)

Author keywords

Enteric microbiota; Food; Food allergy; Food intolerance; Irritable bowel syndrome; Probiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

BACTERIAL METABOLISM; DIET RESTRICTION; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; FOOD ALLERGY; FOOD CONTAMINATION; FOOD INTAKE; HUMAN; INTESTINE FLORA; IRRITABLE COLON; NUTRITIONAL INTOLERANCE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

DIETARY SUPPLEMENTS; ENTERITIS; FOOD; HUMANS; IRRITABLE BOWEL SYNDROME; PROBIOTICS;

EID: 70449514117     PISSN: 17512972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2009.00392.x     Document Type: Review

References (127)

1. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003, 17:643-50.
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006, 130:1480-91.
3. Jarrett M, Heitkemper MM, Bond EF, Georges J. Comparison of diet composition in women with and without functional bowel disorder. Gastroenterol Nurs 1994, 16:253-8.
4. Saito YA, Locke GR, Weaver AL, Zinsmeister AR, Talley NJ. Diet and functional gastrointestinal disorders: a population-based case-control study. Am J Gastroenterol 2005, 100:2743-8.
5. Simrén M, Månsson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U, Björnsson ES. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001, 63:108-15.
6. Simren M, Abrahanmasson H, Bjornsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 2001, 48:20-7.
7. Simren M, Agerforz P, Bjornsson ES, Abrahanmasson H. Nutrient-dependent enhancement of rectal sensitivity in irritable bowel syndrome. Neurogastroenterol Motil 2007, 19:20-9.
8. Salvioli B, Serra J, Azpiroz F, Malgelada JR. Impaired small bowel gas propulsion in patients with bloating during intestinal lipid infusion. Am J Gastroenterol 2006, 101:1853-7.
9. Simren M, Abrahanmasson H, Bjornsson ES. Lipid induced colonic hypersensitivity in irritable bowel syndrome: the role of bowel habits, sex and psychological factors. Clin Gastroenterol Hepatol 2007, 5:201-8.
10. Awad RA, Camacho S, Martin J, Rios N. Rectal sensitivity, pelvic floor function and symptoms severity in Hispanic population with irritable bowel syndrome with constipation. Colorectal Dis 2006, 8:488-93.
11. Caldarella MP, Milano A, Laterza F. Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome: Effect of low-fat intraduodenal infusion. Am J Gastroenterol 2005, 100:383-9.
12. Camilleri M, Mckinzie S, Busciglio L. Prospective study of motor, sensory, psychological and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008, 6:772-81.
13. Eisenbruch S, Holtmann G, Oezcan D. Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome? . Am J Gastroenterol 2004, 99:703-10.
14. Ng C, Malcom A, Hansen R, Kellow J. Feeding and colonic distension provoke altered autonomic disturbances in irritable bowel syndrome. Scand J Gastroenterol 2007, 42:441-6.
15. Eisenbruch S, Orr WC. Diarrhea and constipation predominant IBS patients differ in postprandial autonomic and cortisol responses. Am J Gastroenterol 2001, 96:460-6.
16. Sjolund K, Ekman R, Lindgren S, Rehfeld JF. Disturbed motilin and cholecystokinin release in the irritable bowel syndrome. Scand J Gastroenterol 1996, 11:1110-4.
17. Dapoigny M, Stockburgger RW, Azpiroz F, Collins S, Coremans G, Muller-Lissner S. Eating disorders and irritable bowel syndrome: Is there any link? . Digestion 2003, 67:225-33.
18. Tang TN, Toner BB, Stuckless N, Dion KL, Kaplan AS, Ali A. Features of eating disorders in patients with irritable bowel syndrome. J Psychosomatic Res 1998, 45:171-8.
19. Wallis DJ, Heatherington MM. Emotions and eating: self reported and experimentally induced changes in food intake under stress. Appetite 2009, 52:355-62.
20. Torres SJ, Nowson CA. Relationships between stress, eating behaviour and obesity. Nutrition 2007, 23:887-94.
21. Pérez-De La Cruz V, Konigsberg M, Santamaria A. Kynurenine pathway and disease: an overview. CNS Neurol Disord Drug Targets 2007, 6:398-410.
22. Shufflebotham J, Hood S, Hendry J. Acute tryptophan depletion alters gastrointestinal and anxiety symptoms in irritable bowel syndrome. Am J Gastroenterol 2006, 101:2582-7.
23. Clarke G, Fitzgerald P, Cryan JF, Cassidy EM, Quigley EM, Dinan TG. Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterol 2009, 9:6.
24. Nanda R, James R, Smith H, Dudley CR, Jewell DP. Food intolerance and the irritable bowel syndrome. Gut 1989, 30:1099-104.
25. Nelis GF, Vermeeren MA, Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology 1990, 99:1016-20.
26. Born P, Vierling T, Barina W. Fructose malabsorption and the irritable bowel syndrome. Gastroenterology 1991, 101:1454.
27. Newcomer AD, McGill DB. Irritable bowel syndrome. Role of lactase deficiency. Mayo Clin Proc 1983, 58:339-41.
28. Vernia P, Ricciardi MR, Frandina C, Bilotta T, Frieri G. Lactose malabsorption and irritable bowel syndrome. Effect of a long-term lactose-free diet. Ital J Gastroenterol 1995, 27:117-21.
29. Gremse DA, Nguyenduc GH, Sacks AI, Dipalma JA. Irritable bowel syndrome and lactose maldigestion in recurrent abdominal pain in childhood. South Med J 1999, 92:778-81.
30. Goldstein R, Braverman D, Stankiewicz H. Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints. Isr Med Assoc J 2000, 2:583.
31. Parker TJ, Woolner JT, Prevost AT, Tuffnell Q, Shorthouse M, Hunter JO. Irritable bowel syndrome: is the search for lactose intolerance justified?. Eur J Gastroenterol Hepatol 2001, 13:219-25.
32. Böhmer CJ, Tuynman HA. The effect of a lactose-restricted diet in patients with a positive lactose tolerance test, earlier diagnosed as irritable bowel syndrome: a 5-year follow-up study. Eur J Gastroenterol Hepatol 2001, 13:941-4.
33. Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome - etiology, prevalence and consequences. Eur J Clin Nutr 2006, 60:667-72.
34. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006, 106:1631-9.
35. Zwetchkenbaum J, Burakoff R. The irritable bowel syndrome and food hypersensitivity. Ann Allergy 1988, 61:47-9.
36. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: Guidelines for effective dietary management. J Am Diet Ass 2006, 106:1631-9.
37. Shepherd SJ, Parker FC, Muir SG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized controlled evidence. Clin Gastroenterol Hepatol 2008, 6:765-71.
38. Mckee AM, Prior A, Whorwell PJ. Exclusion diets in irritable bowel syndrome: are they worthwhile?. J Clin Gastroenterol 1987, 9:526-8.
39. Stefanini GF, Saggioro A, Alvisi V. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol 1995, 30:535-41.
40. Zar S, Benson MJ, Kumar D. Food-specific serum igG4 and igE titers to common food antigens in irritable bowel syndrome. Am J Gastroenterol 2005, 100:1550-7.
41. Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil 2006, 18:595-607.
42. Uz E, Türkay C, Aytac S, Bavbek N. Risk factors for irritable bowel syndrome in Turkish population: role of food allergy. J Clin Gastroenterol 2007, 41:380-3.
43. Neri M, Laterza F, Howell S. Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. Eur J Gastroenterol Hepatol 2000, 12:981-8.
44. Zar S, Mincher L, Benson MJ, Kumar D. Food-specific igG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome. Scand J Gastroenterol 2005, 40:800-7.
45. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on igG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004, 53:1459-64.
46. Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther 2001, 15:439-49.
47. Wahnschaffe U, Ullrich R, Riecken EO, Schulzke JD. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001, 121:1329-38.
48. O'Leary C, Wieneke P, Buckley S. Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol 2002, 97:1463-7.
49. Mein SM, Ladabaum U. Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis. Aliment Pharmacol Ther 2004, 19:1199-210.
50. Spiegel BM, Derosa VP, Gralnek IM, Wang V, Dulai GS. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology 2004, 126:1721-32.
51. Adler SN, Jacob H, Lijovetzky G, Mulder CJ, Zwiers A. Positive coeliac serology in irritable bowel syndrome patients with normal duodenal biopsies: Video capsule endoscopy findings and HLA-DQ typing may affect clinical management. J Gastrointest Liver Dis 2006, 15:221-5.
52. Sanders DS, Carter MJ, Hurlstone DP. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001, 358:1504-8.
53. Wahnschaffe U, Schulzke JD, Zeitz M, Ullrich R. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007, 5:844-50.
54. Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the " no man's land" of gluten sensitivity. Am J Gastroenterol 2009, 104:1587-94.
55. Mendall MA, Kumar D. Antibiotics, childhood affluence and irritable bowel syndrome. Eur J Gastroenterol Hepatol 1998, 10:59-62.
56. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003, 124:1662-71.
57. McKendrick MW, Read MW. Irritable bowel syndrome-post salmonella infection. J Infect 1994, 29:1-3.
58. Neal KR, Hebdon J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome. Br Med J 1997, 314:779-82.
59. Garcia Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. Br Med J 1999, 318:565-6.
60. Gwee KA, Graham JC, Mckendrick MW. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996, 347:150.
61. Gwee KA, Leong YL, Graham C. The role of psychological and biological factors in post-infective gut dysfunction. Gut 1999, 44:400-6.
62. Spiller RC, Jenkins D, Thornley JP. Increased rectal mucosal enteroendocrine cells T lymphocytes and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000, 47:804-11.
63. Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003, 125:1651-9.
64. Mearin F, Perez-Oliveras M, Perello A. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005, 129:98-104.
65. Marshall JK, Thabane M, Garg AX. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006, 131:445-50.
66. Tornblom H, Holmvall P, Svenungsson B, Lindberg G. Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol 2007, 5:461-4.
67. Spence MJ, Moss-Morris R. The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis. Gut 2007, 56:1066-71.
68. Ruigomez A, Garcia Rodriguez LA, Panes J. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities. Clin Gastroenterol Hepatol 2007, 5:465-9.
69. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007, 26:535-44.
70. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut 2002, 51:410-3.
71. Stark D, Van Hal S, Marriott D, Ellis J, Harkness J. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol 2007, 37:11-20.
72. Grazioli B, Matera G, Laratta C. Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study. World J Gastroenterol 2006, 12:1941-4.
73. Marshall JK, Thabane M, Borgaonkar MR, James C. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol 2007, 5:457-60.
74. Borgaonkar MR, Ford DC, Marshall JK, Churchill E, Collins SM. The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection. Dig Dis Sci 2006, 51:1026-32.
75. Bradley HK, Wyatt GM, Bayliss CE, Hunter JO. Instability in the faecal flora of a patient suffering from food-related irritable bowel syndrome. J Med Microbiol 1987, 23:29-32.
76. Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004, 10:1802-5.
77. Malinen E, Rinttila T, Kajander K. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005, 100:373-82.
78. Matto J, Maunuksela L, Kajander K. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome - a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005, 43:213-22.
79. Kassinen A, Krogius-Kurikka L, Mäkivuokko H. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007, 133:24-33.
80. Azpiroz F, Malagelada J-R. Abdominal bloating. Gastroenterology 2005, 129:1060-78.
81. Galati JS, Mckee DP, Quigley EMM. The response to intraluminal gas in the irritable bowel syndrome: motility versus perception. Dig Dis Sci 1995, 40.
82. Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol 1996, 91:1579-85.
83. O'Sullivan MA, O'Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 2000, 32:302-4.
84. Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000, 95:1231-8.
85. Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001, 152:735-41.
86. Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001, 13:1143-7.
87. Sen S, Mullan MM, Parker TJ, Woolner JT, Tarry SA, Hunter JO. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002, 47:2615-20.
88. Bazzocchi G, Gionchetti P, Almerigi PF, Amadini C, Campieri M. Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome. Dig Liver Dis 2002, 34(2):s48-53. Suppl
89. Parker P, McNaught CE, Anderson ADG, Mitchell CJ, Macfie J. Synbiotic in irritable bowel syndrome: a double blind prospective randomised controlled trial. Gut 2003, 52:A11.
90. Kim HJ, Camilleri M, Mckenzie S, Lempke MB, Burton DD. A randomized controlled trail of a probiotic, VSL#3 on gut transit and symptoms in diarrhoea-predominant IBS. Aliment Pharmacol Ther 2003, 17:895-904.
91. Tsuchiya J, Barreto R, Okura R, Kawakita S, Fesce E, Marotta F. Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome. Chin J Dig Dis 2004, 5:169-74.
92. Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 2005, 147:197-201.
93. Kim HJ, Vazquez Roque MI, Camilleri M. A randomized controlled trial of probiotic combination VSL#3 and placebo in IBS with bloating. Neurogastroenterol Motil 2005, 17:687-96.
94. Kajander K, Hatakka K, Poussa T, Farkkila M, Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 2005, 22:387-94.
95. Niv E, Naftali T, Hallak R, Vaisman N. The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome - a double blind, placebo-controlled, randomized study. Clin Nutr 2005, 24:925-31.
96. Guyonnet D, Chassany O, Ducrotte P. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary acre: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007, 26:475-86.
97. Kajander K, Myllyluoma E, Rajilić-Stojanović M. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 2008, 27:48-57.
98. Enck P, Zimmermann K, Menke G, Müller-Lissner S, Martens U, Klosterhalfen S. A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome - a randomized controlled trial with primary care physicians. Neurogastroenterol Motil 2008, 20:1103-9.
99. Williams E, Stimpson J, Wang D. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment Pharmacol Ther 2008, 29:97-103. epublication ahead of print
100. Enck P, Zimmermann K, Menke G, Klosterhalfen S. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo. Z Gastroenterol 2009, 47:209-14.
101. Barrett JS, Canale KE, Gearry RB, Irving PM, Gibson PR. Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol 2008, 14:5020-4.
102. Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2008, 32:147-52.
103. Sinn DH, Song JH, Kim HJ. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci 2008, 53:2714-8.
104. Hamilton-Miller JMT. Probiotics in the management of irritable bowel syndrome: a review of clinical trials. Microb Ecol Health Dis 2001, 13:212-16.
105. Quigley EMM. The use of probiotics in functional bowel disease. Gastroenterol Clin N Am 2005, 34:533-45.
106. Quigley EM, Flourie B. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil 2007, 19:166-72.
107. Quigley EM. Germs, gas and the gut; the evolving role of the enteric flora in IBS. Am J Gastroenterol 2006, 101:334-5.
108. Agrawal A, Houghton LA, Morris J. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2008, 29:104-14. Epub ahead of print
109. Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 2009, 9:15.
110. Nikfar S, Rahimi R, Rahimi F, Derakhshani S, Abdollahi M. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum 2008, 51:1775-80.
111. Mcfarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008, 14:2650-61.
112. Moayyedi P, Ford AC, Talley NJ. The efficacy of probiotics in the therapy of irritable bowel syndrome: a systematic review. Gut 2008, epublication ahead of print
113. Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 2009, 104:1033-49.
114. Whorwell PJ, Altringer L, Morel J. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006, 101:326-33.
115. O'Mahony L, Mccarthy J, Kelly P. A randomized, placebo-controlled, double-blind comparison of the probiotic bacteria lactobacillus and bifidobacterium in irritable bowel syndrome (IBS): symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128:541-51.
116. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2009, 29:508-18.
117. Andriulli A, Neri M, Loguercio C. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study. J Clin Gastroenterol 2008, 42(2):S218-23. Pt
118. Quigley EM. Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?. Chin J Dig Dis 2005, 6:122-32.
119. Hillman LC, Stace NH, Fisher A, Pomare EW. Dietary intakes and stool characteristics of patients with the irritable bowel syndrome. Am J Clin Nutr 1982, 36:626-9.
120. Bijkerk CJ, Muris JW, Knottnerus JA, Hoes AW, De Wit NJ. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004, 19:245-51.
121. Brandt LJ, Bjorkman D, Fennerty MB. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002, 97(2):S7-S26. Suppl
122. Quigley EMM, Bergmann J-F, Bytzer P. An evidence-based approach to the management of irritable bowel syndrome in Europe. Eur J Gastroenterol Hepatol 2007, 19(1):S1-37. Suppl
123. Ford AC, Talley NJ, Spiegel BM. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008, 337:a2313.
124. Dear KL, Elia M, Hunter JO. Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome?. Dig Dis Sci 2005, 50:758-66.
125. Lucey MR, Clark ML, Lowndes J, Dawson AM. Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study. Gut 1987, 28:221-5.
126. Burden S. Dietary treatment of irritable bowel syndrome: current evidence and guidelines for future practice. J Hum Nutr Diet 2001, 14:231-41.
127. Dapoigny M, Stockbrügger RW, Azpiroz F. Role of alimentation in irritable bowel syndrome. Digestion 2003, 67:225-33.